Products & Services · Additions
PARI milestones — Additions
This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
StatementSegment
CategoryGrowth
SignalHigher is better
VolatilityVolatile
First reportedQ1 2024
Last reportedQ1 2026
How to read this metric
An increase indicates active investment in expanding the product pipeline, while a decrease suggests a pause in external asset acquisition.
Detailed definition
This metric tracks the capital expenditure or investment made to acquire new intangible assets or milestone rights assoc...
Peer comparison
Similar to 'Additions to Intangible Assets' or 'Acquisition of Licensing Rights' reported by other biotech companies.
Metric ID:
insm_segment_pari_milestones_additionsHistorical Data
9 periods
| Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
Range$0.00 – $0.00
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Insmed's pari milestones — additions?
- Insmed (INSM) reported pari milestones — additions of $0.00 in Q1 2026.
- What does pari milestones — additions mean?
- The total investment made during the period to acquire new intangible assets or rights related to PARI.